You are solely responsible for your interactions with that website. This link will take you to a website to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Vena cava filters are used to help prevent pulmonary embolism that occurs when a blood clot breaks free from the peripheral circulation and travels to the lung, blocking the flow of blood. Each year, approximately 600,000 people experience pulmonary embolism, resulting in an estimated 60,000-100,000 deaths.
Many physicians believe pulmonary embolism is an under-diagnosed condition.
Nitinol, an alloy of nickel and titanium, provides shape-memory properties for easy, predictable placement, as well as the ability for the filter to be constrained to a small size. The low profile 6 French delivery system provides flexibility and support for easy tracking through tortuous vessels, in addition to minimizing patient trauma and insertion site thrombosis. This new filter provides patients and physicians with the smallest, least-invasive permanent vena cava filter available today. Cordis Endovascular is a unit of Cordis Corporation, a broad-based global supplier of leading edge therapies and technologies for circulatory disease management, including interventional medicine, diagnosis and treatment, and electrophysiology. This site is governed solely by applicable U.S. laws and governmental regulations.